共 50 条
Metabolic control of antifungal drug resistance
被引:24
|作者:
Robbins, Nicole
[1
]
Collins, Cathy
[1
]
Morhayim, Jess
[1
]
Cowen, Leah E.
[1
]
机构:
[1] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada
基金:
加拿大自然科学与工程研究理事会;
加拿大健康研究院;
关键词:
Antifungal drug resistance;
Saccharomyces cerevisiae;
Candida albicans;
Azole;
Hsp90;
Calcineurin;
Tor;
Threonine;
Nutrient signaling;
Erg3;
SACCHAROMYCES-CEREVISIAE;
CANDIDA-ALBICANS;
TRANSCRIPTION FACTOR;
GENE-EXPRESSION;
CALCINEURIN;
EVOLUTION;
HSP90;
GROWTH;
PATHWAY;
MECHANISMS;
D O I:
10.1016/j.fgb.2009.07.004
中图分类号:
Q3 [遗传学];
学科分类号:
071007 ;
090102 ;
摘要:
Fungi have evolved an elegant repertoire of mechanisms to survive the cellular stress exerted by antifungal drugs such as azoles, which inhibit ergosterol biosynthesis inducing cell membrane stress. The evolution and maintenance of diverse resistance phenotypes is contingent upon cellular circuitry regulated by the molecular chaperone Hsp90 and its client protein calcineurin. Here, we establish a novel role for nutrients and nutrient signaling in azole resistance. The vulnerability of Saccharomyces cerevisiae azole resistance phenotypes to perturbation was contingent upon specific auxotrophies. Using strains that acquired azole resistance by Erg3 loss of function as a model for resistance that depends on cellular stress responses, we delineated genetic and environmental factors that mitigate the translation of genotype into resistance phenotype. Compromising a global regulator that couples growth and metabolism to environmental cues, Tor kinase, provides a powerful strategy to abrogate drug resistance of S. cerevisiae and Candida albicans with broad therapeutic potential. (c) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:81 / 93
页数:13
相关论文